CMMB

Chemomab Therapeutics Ltd. CMMB

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CMMB KZIA OCEA TOVX ELAB CANF BIVI XRTX INM CERO
6M -58.90 % 47.71 % -87.50 % -55.03 % -72.12 % -76.70 % -86.24 % -35.18 % -48.98 % -98.97 %
YTD -77.23 % 14.29 % -99.83 % -88.31 % -96.69 % -86.33 % -93.62 % -52.91 % -73.96 % -99.93 %
1Y -70.61 % -32.66 % -99.84 % -85.16 % -96.86 % -83.24 % -93.25 % -50.80 % -73.29 % -99.92 %
3Y -79.45 % -63.24 % -99.99 % -98.16 % -99.99 % -96.18 % -99.78 % -91.73 % -95.27 % -100.00 %
5Y -98.63 % -97.83 % -99.99 % -99.78 % -99.99 % -98.67 % -99.91 % -98.05 % -99.92 % -100.00 %
10Y -99.72 % -97.78 % -99.99 % -100.00 % -99.99 % -99.95 % -99.07 % -98.05 % -99.93 % -100.00 %
From the beginning -99.72 % -99.62 % -99.99 % -100.00 % -99.99 % -99.97 % -99.63 % -98.05 % -99.97 % -100.00 %

Dividend

XORTX Therapeutics Inc.